If youre dealing with persistent body fat, have obesity-related health problems, or havent had success with standard weight loss approaches, weight loss peptides could be a valuable solution
Based on its superior efficacy and body composition benefits, experts predict blockbuster status in 2026-2027
Each in Phase 2
Conditions such as rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease, psoriasis, multiple sclerosis, and other autoimmune disorders are not within the approved therapeutic scope of this medication
The most significant safety and efficacy data for retatrutide to date comes from Phase 2 clinical trials, including results published in the New England Journal of Medicine in 2023
The demand for these drugs has skyrocketed, which has created both challenges and new pathways for patients